Management of suspected and known eosinophilic esophagitis-a nationwide survey in Austria.
Wien Klin Wochenschr
; 135(15-16): 406-413, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37071203
ABSTRACT
INTRODUCTION:
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus with increasing incidence and dysphagia as the main symptom. The management of suspected or known EoE by Austrian endoscopists has not been investigated yet.METHODS:
A web-based survey with 13 questions about the management of EoE was sent to endoscopists via the Austrian Society of Gastroenterology and Hepatology (ÖGGH).RESULTS:
A total of 222 endoscopists (74% gastroenterologists, 23% surgeons, and 2% pediatricians; 68% working in a hospital) from all 9 states participated. In patients with dysphagia but a normal appearing esophagus, 85% of respondents reported always taking biopsies; however, surgeons were less likely to obtain biopsies compared to gastroenterologists ("always" 69% vs. 90%, "sometimes" 29% vs. 10%, "never" 2% vs. 0%, pâ¯< 0.001). The approved budesonide orodispersible tablet is the preferred first-line drug used in EoE, ahead of proton pump inhibitors (PPI). Only 65% of participants monitor the patients by endoscopy and histology after 12 weeks of induction therapy, 26% do not continue maintenance therapy, and 22% monitor patients only when symptomatic.CONCLUSION:
The vast majority of Austrian endoscopists adhere to the European and US guidelines in cases of suspected EoE. In contrast, despite the chronic disease course, a significant percentage of providers indicate not to use maintenance therapy and monitor the patients routinely.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Deglutition Disorders
/
Eosinophilic Esophagitis
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Qualitative_research
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Wien Klin Wochenschr
Year:
2023
Document type:
Article
Affiliation country:
Austria